QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IONS

QT34Ionis Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
74.12
-0.19-0.26%
OverviewShort InterestFilings
IONSQT34Ionis Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
74.12-0.26%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.09
Insider Own1.68%
Shs Outstand165.26M
Perf Week0.41%
Market Cap12.28BForward P/E-EPS next Y-1.17Insider Trans0.55%Shs Float-Perf Month0.38%
Enterprise Value14.15BPEG7.00EPS next Q-0.92Inst Own-Short Float-Perf Quarter3.93%
Income-327893636.00P/S11.61EPS this Y-73.07%Inst Trans-Short Ratio-Perf Half Y-5.42%
Sales1.06BP/B24.93EPS next Y67.56%ROA-9.47%Short Interest-Perf YTD-6.31%
Book/sh2.97P/C-EPS next 5Y-ROE-58.57%52W High86.74 -14.55%Perf Year105.03%
Cash/sh11.61P/FCF-EPS past 3/5Y-ROIC-11.14%52W Low36.11 105.26%Perf 3Y-
Dividend Est.-EV/EBITDA3.09Sales past 3/5Y17.16% 5.30%Gross Margin98.35%Volatility1.73% 1.82%Perf 5Y-
Dividend TTM-EV/Sales13.37EPS Y/Y TTM43.42%Oper. Margin-33.35%ATR (14)2.12Perf 10Y-
Dividend Ex-Date-Quick Ratio4.09Sales Y/Y TTM50.07%Profit Margin-30.87%RSI (14)48.48Recom2.20
Dividend Gr. 3/5Y-Current Ratio4.10EPS Q/Q25.33%SMA20-0.75%Beta0.42Target Price109.44
Payout0.00%Debt/Eq4.15Sales Q/Q86.36%SMA50-1.04%Rel Volume1.69Prev Close74.31
Employees1,069LT Debt/Eq4.42EarningsAug 05SMA200-1.17%Avg Volume1.77MPrice74.12
IPO DateMay 17, 1991Option/ShortYes / YesEPS/Sales Surpr.34.12% 25.51%Net Debt/EBITDA0.41Volume2,984,074Change-0.26%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-30-26ReiteratedOppenheimerOutperform$104 → $111
Apr-30-26ReiteratedH.C. Wainwright$120 → $125
Apr-30-26ReiteratedBarclaysOverweight$95 → $115
Apr-21-26ReiteratedMorgan StanleyOverweight$95 → $130
Apr-20-26InitiatedCanaccordBuy$110
Apr-10-26ResumedRaymond JamesOutperform$75 → $104
Feb-25-26ReiteratedMorgan StanleyOverweight$94 → $95
Feb-06-26ReiteratedPiper SandlerOverweight$77 → $87
Jan-05-26ReiteratedWells FargoOverweight$82 → $100
Dec-17-25ReiteratedRBC CapitalOutperform$80 → $95
Latest News
Jun-17-26
Jun-17-2610:53AM
Leerink Partners Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $122Benzinga
Jun-15-26
Jun-15-2607:07PM
Ionis Pharmaceuticals, Inc. (IONS) Presents at National Lipid Association (NLA) 2026 Scientific Sessions - SlideshowSeekingAlpha
12:30PM
Ionis Pharmaceuticals, Inc. (IONS) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - SlideshowSeekingAlpha
12:30PM
TD Cowen Reiterates Buy on Ionis Pharmaceuticals, Maintains $108 Price TargetBenzinga
09:39AM
Intellia's One-Time Gene Editing Therapy Gains Ground Against Rivals In Rare Swelling DisorderBenzinga
Jun-10-26
Jun-10-2601:22PM
Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,058944705
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A171611
Gross Profit1,040928694
Selling, General and Administrative Excl. Other468394268
Research and Development925916902
Other Operating Expense10-1
Operating Income-352-382-475
Interest Expense909190
Unusual Expense
———
Non-Operating Income (Expense)-104-75-99
Net Income Before Taxes-324-380-460
Income Taxes11-6
Consolidated Net Income-327-381-454
Net Income From Continuing Operations-327-381-454
Net Income-327-381-454
EPS (Recurring)-1.99-2.38-3.04
EPS (Basic, Before Extraordinaries)-1.99-2.38-3.04
EPS (Diluted)-2.09-2.38-3.04
EBITDA4,585-287-354
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio11.5613.41—
Gross Margin98.3098.3198.44
Operating Margin-33.27-40.47-67.38
Net Margin-30.91-40.36-64.40
Shares Outstanding165160150
Market Capitalization12,23012,658—
Operating Lease Expense
———
Insider Trading Volume
$78.69$71.00$63.32$55.64$47.95● Close Price0.00M9.90M19.80M29.71M39.61MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BERTHELSEN SPENCER RDirectorJun 15 '26Option Exercise24.4216,000390,720164,013Jun 16 12:00 AM
BERTHELSEN SPENCER RDirectorJun 15 '26Sale73.498,000587,920156,013Jun 16 12:00 AM
Kordasiewicz Holly B.EVP, Chief Development OfficerJun 12 '26Option Exercise53.97121,6926,567,32883,304Jun 16 12:00 AM
Kordasiewicz Holly B.EVP, Chief Development OfficerJun 12 '26Sale73.4160,8464,466,42822,458Jun 16 12:00 AM
BERTHELSEN SPENCER RDirectorJun 01 '26Sale75.678,000605,360156,013Jun 03 12:00 AM
BERTHELSEN SPENCER RDirectorJun 01 '26Option Exercise24.4216,000390,720164,013Jun 03 12:00 AM
Monia Brett PChief Executive OfficerMay 14 '26Option Exercise32.606,440209,944245,882May 15 12:00 AM
Monia Brett PChief Executive OfficerMay 14 '26Sale78.683,220253,347242,662May 15 12:00 AM
Monia Brett PChief Executive OfficerMay 13 '26Option Exercise32.602,63285,804243,978May 15 12:00 AM
Monia Brett PChief Executive OfficerMay 13 '26Sale78.011,316102,665242,662May 15 12:00 AM
LOSCALZO JOSEPHDirectorMay 04 '26Sale75.0677,2895,801,22636,330May 06 12:00 AM
LOSCALZO JOSEPHDirectorMay 04 '26Option Exercise48.74154,5787,534,618113,619May 06 12:00 AM
KLEIN JOSEPH IIIDirectorMay 01 '26Sale73.5110,111743,23811,014May 05 12:00 AM
KLEIN JOSEPH IIIDirectorMay 01 '26Option Exercise47.1120,222952,65821,125May 05 12:00 AM
Baroldi JosephEVP, Chief Business OfficerApr 28 '26Sale71.791,626116,72744,909Apr 30 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR